An “Exacerbate-reverse” Strategy in Yeast Identifies Histone Deacetylase Inhibition as a Correction for Cholesterol and Sphingolipid Transport Defects in Human Niemann-Pick Type C DiseaseAndrew B. Munkacsi, Stephen L. Sturley, Jacob V. Layer et al.|Journal of Biological Chemistry|2011Cited by 91
Normalization of Hepatic Homeostasis in the Npc1 Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor VorinostatAndrew B. Munkacsi, Stephen L. Sturley, Joyce J. Repa et al.|Journal of Biological Chemistry|2016Cited by 35